xdata

What xdata does

XData Lab is a privately held, Chicago-based software company founded in 2023 that builds an AI-driven pharmacovigilance platform for life sciences organizations. The company targets pharmaceutical companies as its primary segment, with healthcare providers as a secondary segment, addressing pain points around drug safety monitoring, adverse event reporting compliance, and FDA regulatory submission requirements. Headcount is reported in the 1–10 range and the firm is at an early operating stage, evidenced by an active website with login and registration functionality and no disclosed ownership, funding, or named customers.

The platform's product surface comprises a core XData Lab product augmented by three integrated modules: a Pharmacovigilance Module for adverse event tracking, case processing, and regulatory compliance; an AI in Drug Safety module applying machine learning for predictive drug safety analytics and signal detection; and a Case Studies module presenting documented customer outcomes. Underlying capabilities span three AI/ML functions: predictive analytics for forecasting adverse drug reactions, anomaly detection for forensic clinical signal identification, and process automation for FDA reporting workflows. The system processes both structured clinical signal data and text-based regulatory documents.

Business model details are not publicly disclosed, including pricing, go-to-market motion, distribution channels, revenue mechanics, and contract structures. No certifications, regulatory clearances, patents, awards, partnerships, management team, customer logos, or funding events are recorded in the available data, indicating the company is in a nascent commercialization phase with minimal external validation on record.

Name

xdata

Website

https://xdata-lab.com

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

1–10 employees

Short description

XData Lab is a Chicago-based, early-stage software company founded in 2023 that offers an AI-driven pharmacovigilance platform for pharmaceutical and biotech companies, providing predictive drug safety analytics, automated FDA reporting, and forensic clinical signal detection.

Ownership category

akta.pro rank

Product category

Pharmacovigilance Software

akta.pro primary industry

Pharmacovigilance & Drug Safety Software (HLAGAJAK)

Keywords

• Pharmacovigilance platform
• Drug safety analytics
• FDA adverse event reporting
• Clinical signal detection
• AI life sciences software

Headquarters

HQ city

Chicago

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Software

Core offering

XData Lab develops an AI-driven pharmacovigilance platform that delivers predictive drug safety analytics, automated FDA adverse event reporting, and forensic clinical signal detection. The platform is targeted at pharmaceutical and biotech companies that need to monitor drug safety and meet FDA regulatory compliance requirements. It combines machine learning-based predictive analytics with process automation for case processing and regulatory submissions.

Product overview

XData Lab is a unified AI-driven pharmacovigilance platform comprising the core XData Lab platform with integrated modules for predictive drug safety analytics, automated FDA reporting, and forensic clinical signal detection. The platform includes dedicated modules for AI-powered drug safety and documented case studies, designed for pharmaceutical and biotech companies requiring regulatory compliance and drug safety monitoring.

Differentiator

Problem solved

Functional benefit

Products and services

• XData Lab Platform Unified AI-driven pharmacovigilance platform that provides predictive drug safety analytics, automated FDA adverse event reporting, and forensic clinical signal detection for pharmaceutical, biotech, and healthcare organizations requiring drug safety monitoring and regulatory compliance.
• Pharmacovigilance Module Provides core pharmacovigilance capabilities for adverse event tracking, individual case processing, and regulatory compliance workflow support, designed for pharmaceutical safety teams and healthcare providers.
• AI in Drug Safety AI-powered drug safety analytics module that uses machine learning models to deliver predictive insights and automated signal detection from clinical and pharmacovigilance data, targeted at pharmaceutical and biotech safety teams.

Segments2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature3 records

Recent moves4 records

Expansion highlights3 records

Direct peers

• ArisGlobal: ArisGlobal's LifeSphere Safety and Multivigilance platforms are among the most established AI-enabled pharmacovigilance suites on the market, offering case processing, signal detection, and regulatory reporting — directly overlapping with XData's core offering.
• Veeva Systems: Veeva's Vault Safety is a leading cloud pharmacovigilance suite used by top-20 pharma, providing case management and regulatory submission workflows — making Veeva a direct competitor to XData's PV and FDA reporting focus.
• Saama Technologies: Saama applies AI/ML across clinical development and pharmacovigilance workflows, including signal detection and case processing automation — making it a comparable AI-first PV technology peer.
• CluePoints: CluePoints provides AI-driven clinical and safety signal detection and risk-based monitoring, overlapping with XData's forensic clinical signal detection capabilities for pharma sponsors and CROs.

Broad incumbents

• Oracle (Health Sciences — Argus Safety): Oracle's Argus Safety is the legacy market-leading pharmacovigilance platform with deep installed base across large pharma, addressing the same adverse event reporting and signal management workflows that XData targets.
• IQVIA: IQVIA combines technology platforms (including safety analytics) with outsourced pharmacovigilance services, addressing the same buyers and workflows as XData across a much broader portfolio.
• Parexel: Parexel is a major CRO offering full-service pharmacovigilance including case processing and regulatory reporting — competing for the same pharma safety budgets, though primarily as services rather than pure SaaS.
• Medidata Solutions (Dassault Systèmes): Medidata's clinical platform ecosystem (Rave) intersects with safety data capture and trial-level signal management in pharma R&D, making it an adjacent incumbent competitor to XData in clinical safety informatics.

Emerging players

• Aetion: Aetion applies AI to real-world evidence and drug safety analytics for pharma, overlapping with XData's predictive safety and signal detection thesis, though from a real-world data vantage point.
• Biofourmis: Biofourmis is an AI-driven health platform combining biosensor data with analytics for safety and outcomes monitoring, representing an emerging adjacent peer exploring AI-enabled safety and continuous monitoring.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/xdatallc

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about xdata